trial

Occupational Recovery After First Episode Psychosis

NCTId NCT03317132
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 109 (actual)
Sponsored by Fraser Health
Primary completion 2020-03
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
109 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2015-03
Primary completion
2020-03
Eligibility
ALL · 19 Years

Interventions & indications

Drugs
IPS

Sponsors

Fraser HealthLead Sponsor
Ministry of Social Development and Poverty Reduction, British ColumbiaCollaborator
Canadian Mental Health AssociationCollaborator

Investigators

1
David H Erickson, PhDPrincipal Investigator

Sites

1 total
New Westminster, Canada

Facts & assertions

4 sourced
Enrollment
109
Phase
NA
Primary Completion Date
2020-03
Status
COMPLETED
relationships
The graph out of here
drug
IPS
drug
lead_sponsor
Fraser Health
company
collaborator
Ministry of Social Development and Poverty Reduction, British Columbia
company
Canadian Mental Health Association
company
indication
Psychosis
indication
Psychotic Disorders
indication
investigator
David H Erickson, PhD
person